Ewing Sarcoma
📧 Sign up to get email alerts when something new happens for Ewing Sarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS other · 2026-04-24Clinical Trial Update: A Study of DXC008 in Patients With Prostate Cancer and Other Solid Tumors [Phase 1]
Phase 1 clinical trial of DXC008 in prostate cancer and other solid tumors is currently recruiting, with Ewing sarcoma among the listed cond…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma [NA]
An update on a clinical trial evaluating adaptive proton therapy for pediatric solid tumors and Hodgkin lymphoma. The trial is currently not…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma [NA]
This clinical trial update notes that a study evaluating targeted oligometastatic radiation for pediatric and young adult patients with soft…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas
ClinicalTrials.gov entry indicates recruitment for a study assessing healing and functional outcomes after reconstruction surgery for bone s…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma [Phase 2]
Phase 2 clinical trial evaluating irinotecan and temozolomide in combination with high-dose alkylator chemotherapy for newly diagnosed Ewing…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS) [Phase 1]
A Phase 1 clinical trial evaluating Xaluritamig in adults, adolescents, and children with relapsed or refractory Ewing sarcoma is currently …
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) [Phase 1]
Phase 1 clinical trial update for a B7-H3–targeted autologous CAR-T cell therapy (3CAR) in pediatric solid tumors, currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies [Phase 1]
Phase 1 trial at New York Medical College evaluating vorinostat in combination with chemotherapy for relapsed/refractory solid tumors and CN…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) [Phase 2]
Phase 2 update from the Pediatric MATCH trial describes targeted therapies matched to tumor genetics in pediatric patients with relapsed or …
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma [Phase 1, Phase 2]
A pediatric Phase 1/2 study is evaluating Onivyde (liposomal irinotecan) in combination with talazoparib or temozolomide in children with re…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas [Phase 1, Phase 2]
Clinical trial update reports ongoing Phase 1/Phase 2 testing of eflornithine (DFMO) with AMXT 1501 for neuroblastoma, CNS tumors, and sarco…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01) [Phase 1, Phase 2]
Substudy 01A of MK-9999-01A (LIGHTBEAM-U01) evaluates Zilovertamab Vedotin in pediatric and young adult participants with hematologic malign…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors [Phase 1, Phase 2]
Clinical trial evaluating silmitasertib (CX-4945) in combination with chemotherapy for relapsed or refractory solid tumors; Phase 1 and Phas…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults [NA]
Overview of the my.naviGATE guide for after-treatment effects in adolescents and young adults with sarcoma and related cancers; the study is…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult Participants [Phase 1]
Phase 1 study evaluating autologous tumor-infiltrating lymphocytes in pediatric, adolescent, and young adult participants with soft tissue s…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Lurbinectedin in FET-Fused Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluates Lurbinectedin in FET-fused tumors such as Ewing sarcoma and desmoplastic small round cell tumor. Recruitment is on…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial) [Phase 2]
Phase 2 pediatric MATCH trial evaluating IDH1-mutant tumors for response to ivosidenib; results for recurrent and refractory solid tumors, l…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Regorafenib in Patients With Refractory Primary Bone Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating regorafenib in patients with refractory primary bone tumors, including osteosarcoma and Ewing sarcoma …
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: A Clinical Study of TK216 in Patients With Relapsed or Refractory Ewing's Sarcoma [Phase 2]
This update concerns a Phase 2 study of TK216 in relapsed or refractory Ewing sarcoma. The trial status is listed as completed.
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas [Phase 1]
Phase 1 dose-escalation study of CLR-131 in children with relapsed or refractory malignant tumors, including neuroblastoma and sarcomas, cur…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Single Arm Romiplostim to Prevent CIT [EARLY_Phase 1]
A single-arm Phase 1 trial is evaluating romiplostim to prevent chemotherapy-induced thrombocytopenia in patients with Ewing sarcoma.
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas [Phase 1]
Phase 1 study update for INBRX-109 in locally advanced or metastatic solid tumors including Ewing sarcoma. The trial is currently recruiting…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes [Phase 1]
Phase 1 clinical trial update for metastatic Ewing sarcoma evaluating a schedule enhancement to improve outcomes; currently recruiting at H.…
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors [Phase 1, Phase 2]
An NCI-sponsored Phase 1/2 trial of vincristine and temozolomide with PEN-866 in adolescents and young adults with relapsed or refractory so…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone
A Mayo Clinic-sponsored trial is evaluating carbon ion therapy, surgery, and proton therapy for pelvic sarcomas involving bone. Recruitment …